VI Articles

Dr. Eric Secemsky shares his decision making rules when choosing which device(s) to use in specific peripheral artery disease (PAD) treatment scenarios.

Endovascular specialists should understand which situations lead to technical and clinical success when deploying drug-eluting stents and drug-coated balloons. Get updated on the safety and efficacy of drug-eluting vascular technologies with insights from Dr. Eric Secemsky.

Laser atherectomy plays an important role in peripheral artery disease treatment. Recent clinical data, including the Pathfinder study, highlight the safety profile and sustained patency rates achieved with novel solid-state laser atherectomy devices, while practical guidance emphasizes maintaining an intraluminal position and optimizing laser settings to enhance procedural outcomes.

Atherectomy has become a pivotal technique utilized in the management of peripheral arterial disease (PAD), offering a versatile approach to plaque removal and vessel preparation. By using a range of devices tailored to specific lesion characteristics, atherectomy can improve the outcomes of subsequent treatments like balloon angioplasty and stenting.

New research with micro-CT has found that Auryon laser atherectomy is effective in disrupting challenging plate-like, circumferential calcium, suggesting a valuable role for this technology in treating complex cases of peripheral artery disease (PAD).

The high-resolution imaging capabilities of Micro-CT are useful in studying calcium in peripheral artery disease (PAD). Dr. John Rundback's cadaveric study uses micro-CT to analyze medial calcium patterns and demonstrates the Auryon laser atherectomy's effectiveness in disrupting challenging calcium buildup.

Dr. Alim Mitha documents the pivotal steps in his journey so far as a medical device entrepreneur working on a new biodegradable flow diverter for cerebral aneurysm treatment.

Biodegradable flow diverters have emerged as an innovative alternative to traditional metal stents for cerebral aneurysm treatment. These new devices offer similar therapeutic benefits without requiring lifelong medication, improving patient outcomes and expanding treatment options in neurosurgery.